Dr. Frank Vocci Receives Final Three Years of UG/UH3 Award

Dr. Nikej Shah of Nirsum Labs and Dr. Frank Vocci of Friends Research Institute have been awarded the final three years of a UG/UH3 grant titled: Development of a Novel Drug for Treating Opioid Use Disorder from the National Institute on Drug Abuse/National Institutes of Health HEAL Initiative. The project will now shift from IND-enabling work to a Phase I Clinical Pharmacology study of NRS-033, an opioid antagonist investigational product, in healthy human male and female volunteers. The objectives of the study will be to assess the safety and tolerability of NRS-033 and its pharmacokinetics in plasma following a single intramuscular injection.